Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Regression of Sebaceous Carcinoma of the Eyelid after a Small Incisional Biopsy: Report of Two Cases.

Brownstein S, Mehta S, Nijhawan N, Allaire G, Nguyen TQT, Tang T, Jiang K, Saleh S, Kalin-Hajdu E, Bruen R, Oestrelcher J.

Ocul Oncol Pathol. 2019 Jun;5(4):252-257. doi: 10.1159/000490706. Epub 2018 Nov 2.

PMID:
31367586
2.

Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid-induced attenuated progression and regression of atherosclerosis.

Bruen R, Curley S, Kajani S, Lynch G, O'Reilly ME, Dillon ET, Fitzsimons S, Mthunzi L, McGillicuddy FC, Belton O.

FASEB J. 2019 Jul 5:fj201900922R. doi: 10.1096/fj.201900922R. [Epub ahead of print]

PMID:
31284764
3.

Liraglutide attenuates pre-established atherosclerosis in apolipoprotein E deficient mice via regulation of immune cell phenotypes and pro-inflammatory mediators.

Bruen R, Curley S, Kajani S, Lynch G, O'Reilly ME, Dillon ET, Brennan EP, Barry M, Sheehan S, McGillicuddy F, Belton O.

J Pharmacol Exp Ther. 2019 Jul 3. pii: jpet.119.258343. doi: 10.1124/jpet.119.258343. [Epub ahead of print]

4.

miR-155 in the Resolution of Atherosclerosis.

Bruen R, Fitzsimons S, Belton O.

Front Pharmacol. 2019 May 14;10:463. doi: 10.3389/fphar.2019.00463. eCollection 2019. Review.

5.

Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.

Melo AM, Zhang L, Dockry ÉF, Petrasca A, Ghnewa YG, Breen EP, Morrissey ME, O'Reilly C, Bruen R, O'Meara A, Lysaght J, Zhu X, Doherty DG.

Glycobiology. 2018 Jul 1;28(7):512-521. doi: 10.1093/glycob/cwy035.

PMID:
29688330
6.

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.

Bruen R, Curley S, Kajani S, Crean D, O'Reilly ME, Lucitt MB, Godson CG, McGillicuddy FC, Belton O.

Cardiovasc Diabetol. 2017 Nov 6;16(1):143. doi: 10.1186/s12933-017-0626-3.

7.

Atheroprotective effects of conjugated linoleic acid.

Bruen R, Fitzsimons S, Belton O.

Br J Clin Pharmacol. 2017 Jan;83(1):46-53. doi: 10.1111/bcp.12948. Epub 2016 May 7. Review.

8.

Persistent migraine aura in an adolescent girl.

Bruen R, Peng SL, Perreault S, Major P, Ospina LH.

J AAPOS. 2013 Aug;17(4):426-7. doi: 10.1016/j.jaapos.2013.03.016. Epub 2013 Jul 16.

PMID:
23871134
9.

Baseline Factors Predictive of SLT Response: A Prospective Study.

Bruen R, Lesk MR, Harasymowycz P.

J Ophthalmol. 2012;2012:642869. doi: 10.1155/2012/642869. Epub 2012 Jul 31.

10.

Reducing wait time for cataract surgery: comparison of 2 historical cohorts of patients in Montreal.

Boisjoly H, Freeman EE, Djafari F, Aubin MJ, Couture S, Bruen RP, Gizicki R, Gresset J.

Can J Ophthalmol. 2010 Apr;45(2):135-9. doi: 10.3129/i09-256.

PMID:
20379297
11.

Cataract-related vision loss and depression in a cohort of patients awaiting cataract surgery.

Freeman EE, Gresset J, Djafari F, Aubin MJ, Couture S, Bruen R, Laporte A, Boisjoly H.

Can J Ophthalmol. 2009 Apr;44(2):171-6. doi: 10.3129/i09-001.

PMID:
19491951
12.

Short-term intraocular pressure changes after intravitreal injection of bevacizumab.

Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J.

Can J Ophthalmol. 2007 Dec;42(6):807-11.

PMID:
18026202

Supplemental Content

Support Center